Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,867 signal articles · 184 in last 24h · 157,418 total before filter · latest 1h ago
184last 24h
864last 7d
140● bullish (7d)
80● bearish (7d)
214publishers
AllMacro199Earnings138M&A102Regulatory18Product20Analyst23
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Meta stock plunges as Zuckerberg’s AI gamble devours its cash
TheStreet59d agobearish
Meta stock plunges as Zuckerberg’s AI gamble devours its cash

Meta Platforms (META) generated the kind of sales growth most firms would be thrilled to see. Wall Street retaliated by cutting about 9% off the stock early Thursday, July 30. Facebook's and Instagram's parent company earned $60.8 billion in sales in the second quarter, up 28% from a year ago. ...

CVS (CVS) Stock Looks Overvalued As 340B Pricing Lawsuit Looms
Simply Wall St.59d agobearish
CVS (CVS) Stock Looks Overvalued As 340B Pricing Lawsuit Looms

CVS Health stock has returned 74.8% over the past year, yet its broader valuation checks lean expensive, so investors are weighing a strong share price run against signals that the stock may already be pricing in a lot of good news. Over the last 12 months, CVS Health has delivered a 74.8% return, which puts recent holders in a strong position and naturally raises the bar for what future returns need to justify today’s price. Expectations around CVS Health’s ability to grow healthcare and...

Circle stock drops after major announcement
TheStreet59d agobearish
Circle stock drops after major announcement

Circle Internet Group (NYSE: CRCL), the company behind the USDC stablecoin, saw its shares fall nearly 7% on July 31 even as it announced a key regulatory milestone ahead of its upcoming quarterly earnings. The cryptocurrency firm is scheduled to report its second-quarter 2026 financial results on ...

Solstice Advanced Materials (SOLS) Stock Still Looks Pricey Despite Its 35% Slump
Simply Wall St.59d agobearish
Solstice Advanced Materials (SOLS) Stock Still Looks Pricey Despite Its 35% Slump

Solstice Advanced Materials has just delivered upbeat news on earnings, an acquisition plan and a dividend, yet the stock has fallen sharply over the past month and current valuation checks suggest the shares do not screen as a clear bargain. The share price is down 35.2% over the past month, which puts recent optimism about the business at odds with how the market is now pricing the stock. Stronger profit delivery and the planned Element Solutions acquisition can support higher earnings...

Nvidia Stock Rises. Thank Amazon.
Barrons.com59d agobearish
Nvidia Stock Rises. Thank Amazon.

Nvidia stock was rising after Amazon raised its capital expenditure forecast and played down competition between its custom AI chips and Nvidia’s processors.

The Why Behind Today's Early Stock Stumble
Barrons.com59d agobearish
The Why Behind Today's Early Stock Stumble

The Dow Jones Industrial Average was up 0.3%, or 182 points, while the S&P 500 rose 0.2%. The tech-heavy Nasdaq Composite gained 0.3%. "Yesterday’s relief rally was justifiable, but it seemed rather extreme by the end of the day and overnight," Interactive Brokers' chief strategist Steve Sosnick told Barron's, adding, "After some of the huge moves it seems prudent to expect some profit taking in stocks and sectors that had monstrous bounces."

Is Intuit (INTU) Undervalued Following Strong Q3 Results And Its AI Restructuring?
Simply Wall St.59d agobearish
Is Intuit (INTU) Undervalued Following Strong Q3 Results And Its AI Restructuring?

Why Intuit Stock Is Back in Focus After Q3 Results Intuit (INTU) is in the spotlight after strong fiscal third quarter results, a 15% year over year revenue gain in Global Business Solutions, and a restructuring that cuts 17% of its workforce to support AI driven plans. See our latest analysis for Intuit. Despite renewed interest after Q3, Intuit’s share price has been volatile, with a 30 day share price return of 18.13% but a year to date share price decline of 49.88%. Over one year, total...

Roblox shares plummet on revenue miss, withdrawn guidance
Proactive59d agobearish
Roblox shares plummet on revenue miss, withdrawn guidance

Roblox Corp (NYSE:RBLX) shares fell nearly 30% to around $34 following the company’s second quarter results, as investors reacted to weaker monetization trends and a cautious outlook despite continued user growth. Roblox reported an adjusted loss of $0.26 per share for the quarter ended June...

Weight Loss Drug Stocks Novo Nordisk, Eli Lilly Slump Below Key Levels
Investor's Business Daily59d agobearish
Weight Loss Drug Stocks Novo Nordisk, Eli Lilly Slump Below Key Levels

Weight loss drug stock leaders slumped on Friday amid updates and ahead of earnings. NVO stock sank under a buy point on trial results. LLY stock dived below support with earnings due next week. Updating the closely watched ZEUS phase 3 clinical trial, Denmark's Novo Nordisk announced overnight that its experimental cardiovascular drug, ziltivekimab — to treat heart disease, kidney disease and inflammation — failed in the late-stage trial.